查加斯病的临床试验:病因和病理生理治疗
Beatriz Matheus de Souza Gonzaga1, Roberto Rodrigues Ferreira1, Laura Lacerda Coelho1
1Laboratório de Inovações em Terapias, Ensino e Bioprodutos - Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Frontiers in microbiology
|January 8, 2024
概括
由于药物选择和副作用有限,查加斯病 (CD) 治疗面临挑战. 正在进行更好的治疗方法的研究,但津醇仍然是目前CD的最佳选择.
科学领域:
- 被忽视的热带疾病被忽视的热带疾病
- 寄生虫学的寄生虫学
- 临床药理学 临床药理学
背景情况:
- 查加斯病 (CD) 是由*Trypanosoma cruzi*引起的,在全球范围内影响着数百万人,主要是在拉丁美洲.
- 疾病呈现急性和慢性阶段,急性阶段的诊断具有挑战性,慢性阶段常见的心脏/消化系统问题.
- 目前的治疗方法,尼达 (BZ) 和尼福蒂莫克斯 (NFX),已超过50年,具有显著的副作用,并且在慢性阶段缺乏有效性.
研究的目的:
- 审查查加斯病病因学和病理生理学治疗临床试验的进展情况.
- 突出现有治疗方法的局限性和需要新的治疗策略.
- 讨论挑战和潜在的方法,如药物重新定位和组合疗法,以推进CD治疗.
主要方法:
- 查加斯病治疗临床试验进展的审查.
- 分析当前的治疗选择,包括本兹尼达和尼福蒂莫克斯.
- 讨论药物开发和研究被忽视疾病的挑战.
主要成果:
- 现有的药物 (BZ,NFX) 有局限性,包括副作用和缺乏慢性阶段疗效.
- 本津醇 (BZ) 目前是最推的治疗方法,特别是在急性阶段.
- 目前正在进行的临床试验旨在优化治疗方案,重点关注剂量和持续时间.
结论:
- 对于查加斯病慢性阶段的新型有效药物有着迫切的需要.
- 药物重新定位和组合疗法是有希望的具有成本效益的战略.
- 进一步的研究和投资对于克服障碍和开发更好的CD治疗方法至关重要.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


